Where to Go from Here? The FDA RIF and Its Impact on the Medical Products Industry

June 25, 2025 | 2:00PM–3:30PM ET | Live Webinar

Overview

Where to Go from Here? The FDA RIF and Its Impact on the Medical Products Industry
June 25, 2025 | 2:00PM – 3:30PM ET | Live Webinar
 
On April 1, FDA eliminated approximately 3,500 positions. What do these reductions and organizational changes mean for how industry engages with FDA on product reviews, postmarket compliance, guidances, and public health research? Panelists will offer insights into FDA’s evolving structure, implications of staff departures on product review and approval, potential disruptions to user fee negotiations, and practical tips for regulated industry on how to move forward during this period of transition. 

Register

$149

Members

$249

Non-Members

$29

Student

Speakers

A woman with a closed-mouth smile, peach skin, shoulder-length strawberry-blonde hair, wearing a white jacket, black top underneath, and a long necklace.

E. Cartier Esham
Read Bio
CEO and Founder, Esham Strategies, LLC

Pictured: A smiling woman with tanned ivory skin, long dark blonde hair, and gold rimmed glasses, wearing a black top.

Megan Elise Howard
Read Bio
Associate, Covington & Burling LLP

A smiling woman with light pink skin, brown-blonde hair, gold hood earrings, wearing a grey jacket, and a white-collared shirt underneath.

Danielle C. Humphrey
Read Bio
VP Compliance Officer & Chief Regulatory Counsel, Becton Dickinson (BD)

Kurt R. Karst
Read Bio
Director, Hyman, Phelps & McNamara, P.C.

Moderated By Rachel Turow
Read Bio
Of Counsel, Skadden, Arps, Slate, Meagher & Flom LLP